Funds and ETFs Clover Biopharmaceuticals, Ltd.
Equities
2197
KYG2280A1076
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 HKD | 0.00% | -7.61% | -31.45% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
ETFs positioned on Clover Biopharmaceuticals, Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 4 M€ | -27.92% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.45% | 70.56M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 2197 Stock
- Funds and ETFs Clover Biopharmaceuticals, Ltd.